Skip to main content
. 2022 Oct 31;12:1010660. doi: 10.3389/fonc.2022.1010660

Table 2.

Profile of blood markers in study patients and healthy controls.

Patients at baseline vs. ctrl (n=15) Levels under treatment LR vs. RP 1 irAE
Marker untreated pretreated 2+L-IO vs. untreated(n=204) ICT (vs. baseline) 1L-IO (vs. baseline) 2+L-IO (vs. baseline) baseline 1 under treatment baseline vs. ctrl 1
all 1L(n=154) ICT(n=108) 1L-IO(n=46) 2+L-IO(n=50) C1 vs. bl(n=27) C4 vs bl(n=67) PD vs. C4(n=10) C1(n=11) C4(n=28) PD vs. C4(n=6) C4(n=26) PD vs. C4(n=9) C1 1 C4 1 PD 1
IL-1β FC>10
p=0.055
FC>10
p=0.028
FC>10
p=0.202
FC>10
p=0.157
FC=0.2
p=0.316
FC=1
p=1
FC=1.2
p=0.959
FC<0.1
p=0.18
FC<0.1
p=0.317
FC=14
p=0.593
FC=1
p=1
FC=0.1
p=0.655
FC=1
p=1
FC=0.8-3
p>0.5
FC=1
p>0.5
FC=1.4-10
p>0.07
FC=0.1-10
p>0.3
FC=7
p=0.009$
IL-2 FC=3
p=0.328
FC=4
p=0.397
FC=1.4
p=0.265
FC=0.7
p=0.024
FC=0.2
p=0.005
FC=0.5
p=0.18
FC=0.8
p=0.674
FC<0.1
p=0.18
FC=0.3
p=0.317
FC=27
p=0.317
FC=1
p=1
FC=0.7
p=0.686
FC<0.1
p=0.317
FC=0.8-9
p=>0.2
FC>10
p>0.35
FC=0.5-10
p>0.6
FC<0.1-1
p>0.4
FC=0.1-4
p>0.1
IL-4 FC=148
p=0.128
FC=225
p=0.104
FC=1.8
p=0.241
FC=4
p=0.121
FC<0.1
p=0.804
FC=0.1
p=0.109
FC<0.1
p=0.019
FC<0.1
p=0.109
FC=0.6
p=0.715
FC=7
p=0.786
FC=0.1
p=0.285
FC=1.3
p=0.753
FC=0.3
p=0.18
FC=0.5-49
p>0.5
FC>10
p>0.40
FC=0.2-10
p>0.1
FC=0.7-10
p>0.3
FC=1.7-88
p>0.06
IL-5 FC=7 p=0.052 FC=6
p=0.052
FC=10
p=0.073
FC=2
p=0.32
FC=0.3
p=0.180
FC<0.1
p=0.08
FC=1.1
p=0.701
FC<0.1
p=0.285
FC=0.3
p=0.273
FC=1.4
p=0.61
FC<0.1
p=0.317
FC=2
p=0.686
FC=1
p=1
FC=3-213
p=0.03-0.5
FC<0.1-10
p>0.4
FC=6-10
p>0.19
FC<0.1-1
p>0.8
FC=4 p=0.011$
FC=17
p=0.003#
IL-6 FC=31 p=0.0002 FC=20 p=0.004 FC=56 p=10-6 FC=49 p=5E-06 FC=1.6
p=0.0007
FC=0.2
p=0.002
FC=6
p=0.695
FC=0.6
p=0.508
FC=0.8
p=0.575
FC=0.5 p=0.043 FC=0.4
p=0.5
FC=0.5
p=0.086
FC=2
p=0.327
FC=0.7
p=0.005$
FC=0.1-0.8
p>0.4
FC<0.1-2
p>0.11
FC=0.1-12
p>0.11
FC=0.4-1
p>0.2
IL-8 FC=25 p=4E-08 FC=17 p=1E-07 FC=42
p=3x10-7
FC=34 p=7x10-8 FC=1.4
p=0.052
FC=0.3
p=0.003
FC=0.7
p=0.025
FC=0.5
p=0.799
FC=0.5
p=0.062
FC=0.4
p=0.179
FC=0.5
p=0.345
FC=0.7
p=0.238
FC=3
p=0.314
FC=0.7
p=0.02-0.6
FC=1.7-1.9
p>0.16
FC=0.5-1.4
p>0.3
FC=0.6-4
p>0.13
FC=1.6 p=0.028 $
IL-10 FC=11 p=0.0002 FC=11 p=3E-04 FC=11
p=4x10-4
FC=9
p=4E-06
FC=0.3
p=0.231
FC=1.3
p=0.314
FC=1.7
p=0.215
FC<0.1
p=0.08
FC=3
p=1
FC=1.3
p=0.913
FC=0.5
p=0.273
FC=1.3
p=0.753
FC=0.7
p=0.893
FC=1-2
p>0.4
FC=0.7-10
p>0.2
FC=0.4-7
p>0.2
FC<0.1-10
p=0.03-0.7
FC=3 p=0.004 $
IP-10 FC=1.4
p=0.497
FC=1.1
p=0.688
FC=2 p=0.006 FC=2 p=0.006 FC=1.4
p=0.011
FC=1.7
p=0.349
FC=1.7
p=0.001
FC=0.9
p=0.575
FC=3
p=0.062
FC=1.4 p=0.031 FC=0.6
p=0.075
FC=0.9
p=0.159
FC=2
p=0.314
FC=0.7-0.8
p=0.04-0.4
FC=0.2-1.5
p>0.1
FC=0.3-0.7
p>0.1
FC=0.6-1.4
p>0.1
FC=0.6-1.4
p>0.1
IL-12p70 FC=1.2
p=0.954
FC=1.3
p=0.689
FC=1.2
p=0.519
FC=0.4
p=0.397
FC=0.3
p=0.253
FC=0.5
p=0.012
FC=0.8
p=0.638
FC=0.2
p=0.144
FC=0.3
p=0.465
FC=1.6
p=0.893
FC=1
p=1
FC=7
p=0.593
FC>10
p=0.18
FC=0.4
p>0.05
FC>10
p>0.2
FC=0.6->10
p>0.3
FC=1-17
p>0.4
FC=4
p=0.019$
FC=9
p=0.014#
IL-17F FC>10
p=0.529
FC>10
p=0.515
FC>10
p=0.421
FC>10
p=0.584
FC=0.01
p=0.805
FC=1
p=1
FC<0.1
p=0.317
FC=1
p=1
FC=1
p=1
FC=46
p=0.285
FC=1
p=1
FC<0.1
p=0.317
FC=1
p=1
FC>10
p>0.19
FC=1
p=1
FC=1->10
p>0.5
FC=1
p=1
FC<0.1-10
p=0.5-0.4
CCL5 FC=1.4 p=0.026 FC=1.4 p=0.016 FC=1.2
p=0.132
FC=1.9
p=0.001
FC=1.4
p=0.002
FC=1.2
p=0.088
FC=1.05 p=0.358 FC=0.9
p=0.646
FC=0.9
p=0.79
FC=1.1
p=0.767
FC=0.7
p=0.463
FC=0.7 p=0.012 FC=1.1
p=0.374
FC=0.8-1.1
p>0.17
FC=0.9-1.1
p>0.4
FC=0.7-0.8
p>0.07
FC=8-1.2
p>0.3
FC=0.7-0.9
p>0.08
sCD40L FC=0.9
p=0.141
FC=0.9
p=0.228
FC=0.8
p=0.092
FC=1
p=0.213
FC=1.1
p=0.859
FC=1.1
p=0.829
FC=1
p=0.336
FC=1.1 p=0.114 FC=0.5 p=0.003 FC=1
p=0.946
FC=0.8
p=0.753
FC=1
p=0.581
FC=1
p=0.767
FC=0.7-1.1
p=0.05-0.7
FC=0.6-1.9
p>0.1
FC=0.5-1.1
p>0.1
FC=1.1-1.3
p>0.1
FC=0.5-1.2
p=0.01-0.6
G-CSF FC=5 p=0.004 FC=6
p=10-4
FC=2
p=0.564
FC=1.6
p=0.297
FC=0.3
p=0.008
FC=2
p=0.001
FC=0.4
p=0.733
FC=0.6 p=0.285 FC=0.9
p=0.328
FC=1.3
p=0.889
FC=0.2
p=0.116
FC=1
p=0.689
FC=1.7
p=0.213
FC=0.4-1.5
p>0.3
FC=0.7-1.7
p>0.2
FC=0.5-0.8
p>0.2
FC=0.3-1.7
p=0.05-0.4
FC=0.7
p=0.027$
Granzyme A FC=1.5
p=0.903
FC=1.7
p=0.567
FC=1
p=0.384
FC=1
p=0.72
FC=0.7
p=0.691
FC=0.8
p=0.049
FC=0.7
p=0.797
FC=0.9
p=0.799
FC=1.5
p=0.594
FC=1
p=0.716
FC=0.2
p=0.249
FC=0.5
p=0.551
FC=1.4
p=0.314
FC=0.5-2
p>0.1
FC=0.8-1.9
p>0.08
FC=0.9-2
p>0.1
FC=0.2-0.6
p>0.1
FC=1.3
p=0.003#
ICAM-1 FC=261 p=9x10-7 FC=326
p=4x10-7
FC=110 p=0.0001 FC=2839 p=9x10-7 FC=11
p=0.011
FC=0.3
p=0.203
FC=0.3 p=0.0005 FC=0.8 p=0.59 FC=0.6 p=0.003 FC=0.7 p=0.317 FC=0.2
p=0.917
FC=8
p=0.0004
FC=0.2 p=0.008 FC<0.1-2
p>0.1
FC=0.2-1.8
p>0.03
FC<0.1-24
p>0.15
FC=2-9
p>0.01
FC=0.1-0.5
p>0.2
IFN-γ FC>10
p=0.603
FC>10
p=0.65
FC>10
p=0.382
FC>10
p=0.494
FC=3
p=0.641
FC=1
p=1
FC=1
p=1
FC=1
p=1
FC=1
p=1
FC=4
p=0.317
FC=1
p=1
FC=1
p=1
FC=1
p=1
FC>10
p>0.2
FC=1
p=1
FC=1->10
p>0.6
FC=1
p=1
FC<0.1-10
p>0.1
TNF FC=14
p=0.829
FC=20
p=0.995
FC=2
p=0.587
FC=3
p=0.869
FC=0.2
p=0.488
FC=0.6
p=0.136
FC=0.5
p=0.039
FC=0.4
p=0.345
FC=0.5
p=0.779
FC=23
p=0.695
FC=9
p=0.109
FC=1.2
p=0.79
FC=1.2
p=0.5
FC=0.8.8
p>0.5
FC=1.2-10
p>0.09
FC=0.2-20
p>0.19
FC=0.3-4
p=0.044-1
FC=0.1-6
p=0.02-0.9
TNF-RI FC=1.6 p=0.021 FC=1.5 p=0.03 FC=1.8 p=0.021 FC=1.7
p=0.001
FC=1.1
p=0.095
FC=0.9
p=0.136
FC=0.9
p=0.153
FC=1.2
p=0.074
FC=0.9
p=0.286
FC=0.8
p=0.084
FC=1
p=0.753
FC=0.9
p=0.101
FC=1.2
p=0.374
FC=0.8
p=0.006$
FC=0.5
p=0.003*
FC=0.7-1
p=0.124-1
FC=0.3-0.8
p>0.024
FC=0.4-0.9
p>0.025
FC=0.7-1.1
p>0.062
Angiogenin FC=4
p=0.658
FC=5
p=0.391
FC=3 p=0.582 FC=2
p=0.513
FC=0.5
p=0.45
FC=0.6
p=0.014
FC=0.3 p=7E-05 FC=2
p=0.575
FC=0.7 p=0.006 FC=3
p=0.838
FC<0.1
p=0.463
FC=0.3
p=1E-05
FC=1.1
p=0.859
FC=0.6-3
p>0.031
FC=1-1.5
p>0.4
FC=1.7-31
p>0.018
FC=0.3-1.4
p>0.1
FC=9 p=0.0002 $
VEGF FC=2 p=0.007 FC=2 p=0.003 FC=1.9
p=0.056
FC=2 p=0.017 FC=1.1
p=0.954
FC=1.2
p=0.097
FC=1
p=0.779
FC=1.1 p=0.959 FC=0.8
p=0.182
FC=0.8 p=0.043 FC=1.1
p=0.345
FC=0.7
p=0.101
FC=1.6
p=0.021
FC=0.8-1
p>0.1
FC=0.8
p>0.1
FC=0.3-1
p>0.08
FC=0.7-1.5
p>0.4
FC=0.7-1.3
p>0.2
NLR FC=5
p=10-9
FC=6
p=10-9
FC=5
p=2x10-7
FC=4 p=4x10-7 FC=0.7
p=0.001
FC=0.7
p=0.019
FC=0.6
p=2x10-5
FC=0.9
p=0.388
FC=1.5
p=0.721
FC=0.6
p=0.116
FC=0.9
p=0.465
FC=1.1
p=0.683
FC=1
p=0.594
FC=0.8
p=0.024*
FC=0.5-0.9
p>0.1
FC=0.5
p=0.029*
FC=0.6
p=0.022#
FC=0.6-1.4
p=0.2-1
FC=0.6-1.1
p>0.1

IL, interleukin; IFN-γ, interferon gamma; TNF, tumour necrosis factor; ICAM-1, intercellular adhesion molecule 1; IP-10, interferon-gamma induced protein 10; VEGF, vascular endothelial growth factor; sCD40L, soluble CD40 ligand; G-CSF, granulocyte-colony stimulating factor; CCL5, CC motif chemokine ligand 5; TNF-RI, soluble TNF-receptor I; ICT, immunochemotherapy; 1L-IO, patients receiving PD-(L)1 inhibitors as monotherapy in the first line; ctrl, age-matched healthy controls; 2+L-IO, patients receiving PD-(L)1 inhibitors as monotherapy in the second-or-subsequent lines; BL, baseline; C1, sample after 1 cycle of treatment; C4, sample after 4 cycles of treatment; FC, fold change; NLR, neutrophil-to-lymphocyte ratio; $, for the ICT subgroup; *, for the 1L-IO subgroup; #,for the 2+L-IO subgroup; for detailed results please see Supplementary Table 4 .

Non-parametric statistical comparisons (please see Methods). Comparisons significant after B-H correction (FDR <0.1) are highlighted in green. Results with p<0.05, but FDR >0.1 are highlighted in grey.

1for the group sizes please see Figure 1 .